Small PFS Bump in Synovial Sarcoma With Novel Drug

(MedPage Today) -- The novel multi-targeted tyrosine kinase inhibitor (TKI) catequentinib significantly reduced the risk of disease progression or death in advanced or metastatic synovial sarcoma, a phase III study found.
In arm C of the APROMISS...